Physician profile
Saeed Hashemi
NPI 1831108612
$1,731.05
in general payments reported to CMS, 2019-2025
18 companies · $669 in 2025
The $669 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $232 · 2022: $271 · 2023: $211 · 2024: $348 · 2025: $669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,128.86 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $483.53 | 2023-2025 | Ibsrela |
| Abbvie INC. | $396.13 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $154.33 | 2022-2025 | Xifaxan, Trulance |
| Janssen Biotech, INC. | $140.71 | 2025 | Tremfya, Simponi Aria, Stelara |
| Merck Sharp & Dohme LLC | $84.46 | 2021-2023 | Dificid |
| Phathom Pharmaceuticals, INC. | $78.86 | 2025 | Voquezna |
| Celgene Corporation | $54.03 | 2022-2023 | Zeposia |
| Nestle Healthcare Nutrition INC. | $50.30 | 2022 | |
| Genzyme Corporation | $46.70 | 2023-2024 | |
| Madrigal Pharmaceuticals | $46.28 | 2024-2025 | Rezdiffra, Resmetirom |
| Daiichi Sankyo INC. | $40.07 | 2021-2023 | Injectafer |
| Boston Scientific Corporation | $36.66 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $29.50 | 2025 | Iqirvo |
| Aimmune Therapeutics, INC. | $25.75 | 2024 | |
| Gilead Sciences, INC. | $21.90 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $16.67 | 2023 | Sucraid |
| Ironwood Pharmaceuticals, INC | $14.12 | 2024 | |
| Ethicon US, LLC | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saeed Hashemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.